Verona Pharma (VRNA)
(Delayed Data from NSDQ)
$15.47 USD
+0.16 (1.05%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.47 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/9/24 |
---|---|
Current Quarter | -0.24 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 30.43% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.32 |
Next Year | -0.85 |
EPS (TTM) | -0.69 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 16.90M | 114.95M |
# of Estimates | NA | NA | 5 | 5 |
High Estimate | NA | NA | 31.47M | 166.30M |
Low Estimate | NA | NA | 2.25M | 36.53M |
Year ago Sales | 0.00M | 0.00M | 0.46M | 16.90M |
Year over Year Growth Est. | NA | NA | 3,590.83% | 579.99% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.24 | -0.32 | -1.32 | -0.85 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.24 | -0.32 | -1.28 | -0.40 |
High Estimate | -0.16 | -0.24 | -1.12 | -0.24 |
Low Estimate | -0.30 | -0.40 | -1.60 | -1.60 |
Year ago EPS | -0.24 | -0.11 | -0.72 | -1.32 |
Year over Year Growth Est. | 0.00% | -190.91% | -83.33% | 35.61% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 3 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.24 | -0.32 | -1.32 | -0.85 |
7 Days Ago | -0.24 | -0.32 | -1.32 | -0.85 |
30 Days Ago | -0.24 | -0.32 | -1.23 | -0.61 |
60 Days Ago | -0.26 | -0.26 | -0.97 | -0.28 |
90 Days Ago | -0.26 | -0.26 | -0.97 | -0.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.24 | -0.32 | -1.60 | -1.60 |
Zacks Consensus Estimate | -0.24 | -0.32 | -1.32 | -0.85 |
Earnings ESP | 0.00% | 0.00% | -21.03% | -87.79% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.18 | -0.11 | -0.24 | NA |
Estimate | -0.23 | -0.27 | -0.27 | -0.22 | NA |
Difference | 0.07 | 0.09 | 0.16 | -0.02 | 0.08 |
Surprise | 30.43% | 33.33% | 59.26% | -9.09% | 28.48% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more